Cargando…

Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor

Coronaviruses (CoVs) classified in the Coronaviridae family infect a very large spectrum of vertebrate group. Seven CoVs that cause human disease consist of Alpha-CoVs, which are HCoV-229E, and NL63 and beta-CoVs, which are MERS-CoV, SARS-CoV, HCoV-OC43, HCoV-HKU1, and SARS-CoV-2. SARS-CoV-2 is an e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durmaz, Bengül, Abdulmajed, Olkar, Durmaz, Rıza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Istanbul Medeniyet University 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/ https://www.ncbi.nlm.nih.gov/pubmed/33110678 http://dx.doi.org/10.5222/MMJ.2020.98048

Ejemplares similares

Mycobiome in the Middle Ear Cavity with and Without Otitis Media with Effusion
por: Durmaz, Rıza, et al.
Publicado: (2021)

The effect of gestational weight gain on serum total oxidative stress, total antioxidant capacity and gut microbiota
por: CÖMERT, Tuğba Küçükkasap, et al.
Publicado: (2022)

SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors
por: Mishra, Pushpendra Mani, et al.
Publicado: (2022)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2
por: Mendis, Jenny, et al.
Publicado: (2021)

Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
por: Bhanu, Piyush, et al.
Publicado: (2020)

Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2
por: Priya, Prerna, et al.
Publicado: (2021)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2
por: Golcuk, Mert, et al.
Publicado: (2022)

Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2
por: Hayashi, Takuma, et al.
Publicado: (2021)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals
por: Praharaj, Manas Ranjan, et al.
Publicado: (2022)

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM
por: Xu, Cong, et al.
Publicado: (2021)

Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
por: Rathod, Shravan B., et al.
Publicado: (2020)

Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors
por: Targosz-Korecka, Marta, et al.
Publicado: (2021)

Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues
por: Kim, Sinae, et al.
Publicado: (2021)

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
por: Shen, Min, et al.
Publicado: (2020)

Reply to Hayashi and Konishi: Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between virus and ACE2
por: Tang, Yan-Dong
Publicado: (2021)

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2
por: Corrêa Giron, Carolina, et al.
Publicado: (2020)

Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption
por: Ren, Wenlin, et al.
Publicado: (2021)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
por: Anand, Sai Priya, et al.
Publicado: (2020)

Modelling SARS-CoV-2 spike-protein mutation effects on ACE2 binding
por: Thakur, Shivani, et al.
Publicado: (2023)

Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
por: Song, Wenfei, et al.
Publicado: (2018)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Day, Christopher J., et al.
Publicado: (2021)

GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
por: Tsai, Ming-Shao, et al.
Publicado: (2021)

Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor
por: Mahalingam, Gokulnath, et al.
Publicado: (2023)

SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody
por: Omotuyi, Olaposi, et al.
Publicado: (2022)

Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2
por: Ojha, Rupal, et al.
Publicado: (2022)

Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants
por: Raghu, Deepa, et al.
Publicado: (2022)

Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2020)

SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species
por: Rendon-Marin, Santiago, et al.
Publicado: (2021)

Millisecond dynamic of SARS‐CoV‐2 spike and its interaction with ACE2 receptor and small extracellular vesicles
por: Lim, Keesiang, et al.
Publicado: (2021)

Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study
por: Alavi, Mehran, et al.
Publicado: (2022)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
por: Pei, Gaofeng, et al.
Publicado: (2022)

SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19
por: Nesci, Salvatore
Publicado: (2021)

Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
por: Aljindan, Reem Y., et al.
Publicado: (2021)

Missense mutations in spike protein of SARS‐CoV‐2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor
por: Mahmood, Tousif Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_broerrklclqepvgqqgkv4kie32